Form D — Barricade Therapeutics Corp.
0002090859-26-000008 · filed Jun 10, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- —
- Total sold
- $100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Barricade Therapeutics Corp.
- CIK
- 2090859
- Entity
- Corporation
- Jurisdiction
- DE
- Year incorporated
- 2017
- Address
- 1120 South Freeway, Suite 103
Fort Worth, TX 76104 - Phone
- —
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Neil Thapar · Executive OfficerIrving, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗